"A women's health practice with several locations in New Mexico, we offer our patients the most comprehensive care options so they get the best treatment for everything from routine gynecology check-ups to gynecologic oncology care. We prioritize comfort and wellbeing for each patient with minimally invasive procedures, access to leading clinical trials, and a skilled, supportive team that never leaves your side. We understand that providing excellent care means more than providing the best treatment plans. We take pride in the compassion and understanding we bring to every patient relationship. Our patients are our family and we fight for them with everything we have."

During the past decade, Southwest Gynecologic Oncology Associates Inc conducted 21 clinical trials. In the 10-year time frame, 21 clinical trials started and 30 clinical trials were completed, i.e. on average, 142.9% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 19 clinical trials were completed. i.e. 1900% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Southwest Gynecologic Oncology Associates Inc" #1 sponsor was "National Cancer Institute (NCI)" with 25 trials, followed by "Gynecologic Oncology Group" with 10 trials sponsored, "GOG Foundation" with 8 trials sponsored, "NRG Oncology" with 3 trials sponsored and "Celgene" with 3 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Southwest Gynecologic Oncology Associates Inc" #1 collaborator was "NRG Oncology" with 20 trials as a collaborator, "National Cancer Institute (NCI)" with 20 trials as a collaborator, "Canadian Cancer Trials Group" with 2 trials as a collaborator, "Gynecologic Oncology Group" with 2 trials as a collaborator and "AstraZeneca" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "Southwest Gynecologic Oncology Associates Inc" are "Recurrent Ovarian Carcinoma" (10 trials), "Fallopian Tube Clear Cell Adenocarcinoma" (9 trials), "Fallopian Tube Transitional Cell Carcinoma" (9 trials), "Ovarian Clear Cell Adenocarcinoma" (9 trials) and "Ovarian Transitional Cell Carcinoma" (9 trials). Many other conditions were trialed in "Southwest Gynecologic Oncology Associates Inc" in a lesser frequency.

Most popular intervention types in "Southwest Gynecologic Oncology Associates Inc" are "Drug" (40 trials), "Other" (37 trials), "Biological" (24 trials), "Procedure" (11 trials) and "Radiation" (6 trials). Other intervention types were less common.

The name of intervention was led by "Quality-of-Life Assessment" (23 trials), "Laboratory Biomarker Analysis" (22 trials), "Paclitaxel" (22 trials), "Carboplatin" (18 trials) and "Questionnaire Administration" (12 trials). Other intervention names were less common.

The vast majority of trials in "Southwest Gynecologic Oncology Associates Inc" are 44 trials for "Female" genders and 5 trials for "All" genders.

Currently, there are NaN active trials in "Southwest Gynecologic Oncology Associates Inc". undefined are not yet recruiting, 1 are recruiting, 26 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 15 completed trials in Southwest Gynecologic Oncology Associates Inc, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Southwest Gynecologic Oncology Associates Inc, 3 "Phase 1" clinical trials were conducted, 23 "Phase 2" clinical trials and 26 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".